
Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015. Dr Zeldin will lead …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

